PRGO beats Q3 earnings estimates but misses on sales. It also trims the 2025 outlook and launches a strategic review of its infant formula unit.
Perrigo Company plc ( PRGO ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Bradley Joseph - Vice President of Global Investor Relations & Corporate Communications Patrick Lockwood-Taylor - President, CEO & Director Eduardo Bezerra - Executive VP & CFO Conference Call Participants Susan Anderson - Canaccord Genuity Corp., Research Division Keith Devas - Jefferies LLC, Research Division Ethan Brown - JPMorgan Chase & Co, Research Division Daniel Biolsi - Hedgeye Risk Management LLC Presentation Operator Good morning, ladies and gentlemen, and welcome to Perrigo Q3 2025 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Wednesday, November 5, 2025.
While the top- and bottom-line numbers for Perrigo (PRGO) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
| Specialty Retail Industry | Consumer Discretionary Sector | Patrick Lockwood-Taylor CEO | NYSE Exchange | G97822103 CUSIP |
| IE Country | 8,379 Employees | 28 Nov 2025 Last Dividend | 26 Aug 1993 Last Split | 16 Dec 1991 IPO Date |
Perrigo Company plc is a leading provider of over-the-counter health and wellness solutions, aiming to enhance individual well-being across the United States, Europe, and other international markets. Operating through Consumer Self-Care Americas and Consumer Self-Care International segments, Perrigo specializes in the development, manufacture, marketing, and distribution of consumer self-care products. The company's portfolio includes a wide range of products designed to meet the health care needs of consumers, such as upper respiratory, nutrition, digestive health, pain and sleep-aids, oral care products, and more. It also extends its offerings to healthy lifestyle, skin care, women's health, vitamins, minerals, supplements, rare diseases, and other miscellaneous self-care products. With a history dating back to 1887, Perrigo Company plc, headquartered in Dublin, Ireland, has evolved from its original name, Perrigo Company, reflecting its growth and international presence.
Includes cough suppressants, expectorants, and solutions for sinus and allergy relief. These products are designed to alleviate symptoms associated with colds, flu, and allergies, improving respiratory health.
Comprising infant formulas and nutritional beverages formulated to provide essential nutrients and support for infants and adults, ensuring optimal growth and health.
Features antacids, anti-diarrheal, and anti-heartburn medications aimed at offering relief from various digestive issues, enhancing overall digestive wellness.
Encompasses pain relievers and fever reducers in addition to products that help with sleep, addressing minor aches and pains as well as promoting restful sleep.
Includes toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers, designed to maintain oral hygiene and health.
Offers products for smoking cessation, well-being, and weight management, supporting consumers in achieving a healthier lifestyle and better overall health.
Covers dermatological care, scar management, lice treatment, and other products for various skin conditions, aimed at promoting healthy skin.
Comprises feminine hygiene and contraceptives, addressing women’s health needs with discreet and effective solutions.
Provides a wide array of vitamins, minerals, and supplements designed to support overall health and compensate for dietary deficiencies.
Offers specialized products aimed at treating rare diseases, fulfilling the needs of patients with uncommon medical conditions.
Includes an assortment of additional self-care products catering to a variety of health and well-being needs.
Perrigo also offers contract manufacturing services, providing expertise in the production of high-quality products for third parties.
The company markets its products under several renowned brands, including Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette. These products are distributed through various channels, including retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies, ensuring wide accessibility for consumers.